CD5 and diffuse large B-cell lymphoma: NCT04767308 studies CT125A cells in CLL, MCL, DLBCL, FL, and PTCL, where endogenous CD5 in CT125A cells are knocked out by CRISPR/Cas9 to avoid fratricide during CAR-T cell production.